References
- Stollberger C, Huber JO, Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol. 2005;20:243-251. https://doi.org/10.1097/01.yic.0000166405.49473.70
- Hennessy S, Bilker WB, Knauss JS, Margolis DJ, Kimmel SE, Reynolds RF, Glasser DB, Morrison MF, Strom BL. Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ. 2002;325:1070-1074. https://doi.org/10.1136/bmj.325.7372.1070
- Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry. 2001;58:1161-1167. https://doi.org/10.1001/archpsyc.58.12.1161
- Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL. Thioridazine and sudden unexplained death in psychiatric in-patients. Br J Psychiatry. 2002;180:515-522. https://doi.org/10.1192/bjp.180.6.515
- Straus SM, Bleumink GS, Dieleman JP, van der Lei J, 't Jong GW, Kingma JH, Sturkenboom MC, Stricker BH. Antipsychotics and the risk of sudden cardiac death. Arch Intern Med. 2004;164:1293-1297. https://doi.org/10.1001/archinte.164.12.1293
- Steele JW, Faulds D, Sorkin EM. Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation. Drugs Aging. 1993;3:460-478. https://doi.org/10.2165/00002512-199303050-00007
- Mucci A, Nolfe G, Maj M. Levosulpiride: a review of its clinical use in psychiatry. Pharmacol Res. 1995;31:95-101.
- Capel MM, Colbridge MG, Henry JA. Overdose profiles of new antipsychotic agents. Int J Neuropsychopharmacol. 2000;3:51-54. https://doi.org/10.1017/S1461145700001760
- Huang BH, Hsia CP, Chen CY. Sulpiride induced torsade de pointes. Int J Cardiol. 2007;118:e100-e102. https://doi.org/10.1016/j.ijcard.2007.01.060
- Iglesias E, Esteban E, Zabala S, Gascon A. Tiapride-induced torsade de pointes. Am J Med. 2000;109:509.
- Lin CH, Chen MC, Wang SY, Lin CY. Predictive factors for QTc prolongation in schizophrenic patients taking antipsychotics. J Formos Med Assoc. 2004;103:437-441.
- Su KP, Shen WW, Chuang CL, Chen KP, Chen CC. A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol. Schizophr Res. 2003;59:93-94. https://doi.org/10.1016/S0920-9964(01)00336-X
- Tie H, Walker BD, Valenzuela SM, Breit SN, Campbell TJ. The Heart of Psychotropic drug therapy. Lancet. 2000;355:1825.
-
Choi SY, Koh YS, Jo SH. Inhibition of human ether-a-go-go-related gene
$K^+$ channel and IKr of guinea pig cardiomyocytes by antipsychotic drug trifluoperazine. J Pharmacol Exp Ther. 2005;313:888-895. - Zhou Z, Gong Q, Ye B, Fan Z, Makielski JC, Robertson GA, January CT. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J. 1998;74:230-241. https://doi.org/10.1016/S0006-3495(98)77782-3
- Heath BM, Terrar DA. Separation of the components of the delayed rectifier potassium current using selective blockers of IKr and IKs in guinea-pig isolated ventricular myocytes. Exp Physiol. 1996;81:587-603. https://doi.org/10.1113/expphysiol.1996.sp003961
-
Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier
$K^+$ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195-215. https://doi.org/10.1085/jgp.96.1.195 - Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol. 2001;12:411-420. https://doi.org/10.1046/j.1540-8167.2001.00411.x
- Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labeling. Drug Saf. 2001;24:323-351. https://doi.org/10.2165/00002018-200124050-00001
- Sugiyama A, Satoh Y, Shiina H, Takeda S, Hashimoto K. Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models. J Cardiovasc Pharmacol. 2002;40:235-245. https://doi.org/10.1097/00005344-200208000-00009
- Lenhard G, Kieferndorf U, Berner G, Vogtle-Junkert U, Wagener HH. The importance of pharmacokinetic data on sulpiride: results of a bioequivalence study of two sulpiride 200 mg preparations following oral administration. Int J Clin Pharmacol Ther Toxicol. 1991;29:231-237.
- Bressolle F, Bres J, Blanchin MD, Gomeni R. Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels. J Pharm Sci. 1984;73:1128-1136. https://doi.org/10.1002/jps.2600730826
- Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58:32-45. https://doi.org/10.1016/S0008-6363(02)00846-5
- Kiehn J, Lacerda AE, Wible B, Brown AM. Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilide. Circulation. 1996;94:2572-2579. https://doi.org/10.1161/01.CIR.94.10.2572
- Thomas D, Wendt-Nordahl G, Rockl K, Ficker E, Brown AM, Kiehn J. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. J Pharmacol Exp Ther. 2001;297:753-761.
- Madeja M, Musshoff U, Speckmann EJ. Follicular tissues reduce drug effects on ion channels in oocytes of Xenopus laevis. Eur J Neurosci. 1997;9:599-604. https://doi.org/10.1111/j.1460-9568.1997.tb01636.x
- Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175-187. https://doi.org/10.1016/S0092-8674(00)80728-X
- Curtis LH, Ostbye T, Sendersky V, Hutchison S, Allen LaPointe NM, Al-Khatib SM, Usdin Yasuda S, Dans PE, Wright A, Califf RM, Woosley RL, Schulman KA. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med. 2003;114:135-141. https://doi.org/10.1016/S0002-9343(02)01455-9
- Silvestre JS, Prous JR. Comparative evaluation of hERG potassium channel blockade by antipsychotics. Methods Find Exp Clin Pharmacol. 2007;29:457-465. https://doi.org/10.1358/mf.2007.29.7.1119172
- Lee HA, Kim KS, Park SJ, Kim EJ. Cellular mechanism of the QT prolongation induced by sulpiride. Int J Toxicol. 2009;28:207-212. https://doi.org/10.1177/1091581809337261
-
Ito K, Nakazawa K, Koizumi S, Liu M, Takeuchi K, Hashimoto T, Ohno Y, Inoue K. Inhibition by antipsychotic drugs of L-type
$Ca^{2+}$ channel current in PC12 cells. Eur J Pharmacol. 1996;314:143-150. https://doi.org/10.1016/S0014-2999(96)00500-6 -
Nakazawa K, Ito K, Koizumi S, Ohno Y, Inoue K. Characterization of inhibition by haloperidol and chlorpromazine of a voltage-activated
$K^+$ current in rat phaeochromocytoma cells. Br J Pharmacol. 1995;116:2603-2610. https://doi.org/10.1111/j.1476-5381.1995.tb17214.x
Cited by
- The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project vol.39, pp.1, 2010, https://doi.org/10.1007/s40264-015-0353-1
- Evidence for the hERG Liability of Antihistamines, Antipsychotics, and Anti‐Infective Agents: A Systematic Literature Review From the ARITMO Project vol.57, pp.5, 2010, https://doi.org/10.1002/jcph.838